Anti-influenza drugs

Development of new drugs against influenza has been of great interest. Number of drugs show Anti-influenza properties, but may have altered effects for the use in clinic. These drugs target viral components and some target the host cell elements which help in the viral cycle, but related side effects are the disadvantages. As for now, four antiviral drugs have been discovered against influenza; zanamivir and oseltamivir which inhibit neuraminidase which act in both Influenza A and Influenza B, while rimantadine and amantadine block M2 passage of influenza A.


When a new variety of influenza virus transmits rapidly it may lead to pandemic. Even the drugs may possibly show no effects to same degree. Government maintains a stock of these drugs to use during pandemics. According to FDA three drugs are present which can be used during circulating viruses; Rapivab, Relenza, Tamiflu (oseltamivir which is generic)


  • Clinical trials
  • Influenza and pneumonia
  • Influenza immunization
  • Ethical preparedness

Related Conference of Anti-influenza drugs

Anti-influenza drugs Conference Speakers